<p>Option Care Health（納斯達克股票代碼：OPCH - 獲取免費報告）在週一發佈的報告中被 Zacks Research 的股票分析師從 “持有” 評級下調至 “強烈賣出” 評級，Zacks.com 報道。</p>
<p>獲取 <strong>Option Care Health</strong> 的提醒：</p>
<ul>
<li>Option Care Health 股票正在進行健康的回調</li>
</ul>
<p>其他幾位股票研究分析師也對該公司發表了評論。Jefferies Financial Group 在 1 月 13 日的研究報告中重申了 “買入” 評級，並將 Option Care Health 的目標價設定為 37.00 美元。TD Cowen 在 5 月 1 日的研究報告中將 Option Care Health 的目標價從 37.00 美元下調至 23.00 美元，並對該股票設定了 “持有” 評級。摩根士丹利在 5 月 6 日的研究報告中將 Option Care Health 的目標價設定為 28.00 美元。Citizens Jmp 在 1 月 13 日的研究報告中重申了 “市場跑贏大盤” 評級，並將 Option Care Health 的目標價設定為 38.00 美元（上調自 36.00 美元）。最後，Barrington Research 在 5 月 1 日的研究報告中將 Option Care Health 的目標價從 42.00 美元下調至 32.00 美元，並對該股票設定了 “跑贏大盤” 評級。一位股票研究分析師給予該股票 “強烈買入” 評級，八位給予 “買入” 評級，三位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，平均目標價為 31.25 美元。</p>
<p><strong>獲取我們關於 Option Care Health 的最新股票報告</strong></p>
<h2>Option Care Health 股票下跌 1.2%</h2>
<p>週一，Option Care Health 股票開盤價為 19.59 美元。Option Care Health 的年低為 18.01 美元，年高為 36.80 美元。該公司的債務與股本比率為 0.85，流動比率為 1.64，速動比率為 1.07。該股票的 50 日移動平均線為 27.52 美元，200 日移動平均線為 30.43 美元。該公司的市值為 30.8 億美元，市盈率為 15.19，PEG 比率為 1.10，貝塔值為 0.68。</p>
<p>Option Care Health（納斯達克股票代碼：OPCH - 獲取免費報告）最後一次公佈財報是在 4 月 30 日，報告顯示該公司本季度每股收益為 0.40 美元，超出市場共識預期的 0.37 美元，超出幅度為 0.03 美元。Option Care Health 的股本回報率為 18.17%，淨利潤率為 3.64%。該公司本季度的收入為 13.5 億美元，而分析師預期為 13.9 億美元。在去年同期，該公司每股收益為 0.40 美元。與去年同期相比，該公司的季度收入增長了 1.3%。Option Care Health 已將其 2026 財年的指引設定為 1.820-1.920 每股收益。股票研究分析師預計 Option Care Health 在當前年度將發佈 1.64 每股收益。</p>
<h2>Option Care Health 的內部交易</h2>
<p>在相關消息中，首席執行官 John Charles Rademacher 在 5 月 4 日的交易中購買了 12,500 股該股票。該股票的平均購買成本為每股 21.18 美元，總價值為 264,750.00 美元。完成購買後，首席執行官直接持有該公司 695,152 股股票，價值為 14,723,319.36 美元。這筆交易代表其持股比例增加了 1.83%。該購買在向證券交易委員會的法律文件中披露，可以通過此鏈接訪問。此外，董事 Timothy P. Sullivan 在 5 月 7 日的交易中購買了 24,154 股該股票。該股票的平均購買成本為每股 20.69 美元，總價值為 499,746.26 美元。完成購買後，該董事持有 73,383 股公司的股票，價值約為 1,518,294.27 美元。這筆交易使其持股比例增加了 49.06%。有關此次購買的更多細節可在官方 SEC 披露中找到。在過去的九十天裏，內部人士共購買了 73,264 股公司股票，價值為 1,548,316 美元。目前，1.70% 的股票由內部人士持有。</p>
<h2>Option Care Health 的機構交易</h2>
<p>機構投資者和對沖基金最近修改了對該股票的持有情況。V Square Quantitative Management LLC 在第四季度購買了 Option Care Health 的新股份，價值約為 25,000 美元。Cornerstone Planning Group LLC 在第三季度將其在 Option Care Health 的股份增加了 7,621.4%。Cornerstone Planning Group LLC 現在擁有該公司 1,081 股股票，價值 30,000 美元，此前在上個季度購買了 1,067 股。McIlrath &amp; Eck LLC 在第二季度購買了 Option Care Health 的新股份，價值約為 37,000 美元。Advisory Services Network LLC 在第三季度購買了 Option Care Health 的新股份，價值約為 35,000 美元。最後，Caitong International Asset Management Co. Ltd 在第三季度購買了 Option Care Health 的新股份，價值約為 38,000 美元。98.05% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Option Care Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Option Care Health（納斯達克：OPCH）是美國領先的家庭和替代場所輸液服務提供商。該公司專注於注射療法的管理，包括抗生素、營養、補液、免疫球蛋白、疼痛管理和特殊藥物。通過其全國性的輸液藥房和護理專業人員網絡，Option Care Health 為管理複雜或慢性病的患者提供定製的護理計劃和上門護理服務。</p>
<p>Option Care Health 的當前結構可追溯到 2021 年初與 BioScrip 合併的完成，結合了該行業中兩家經驗最豐富的家庭輸液業務。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Option Care Health</li>
<li>海軍催化劑點燃了 Odysight 的增長引擎</li>
<li>AST SpaceMobile 因銀河 Q1 業績不佳而暴跌：垂直整合能拯救這家 SpaceX 競爭對手嗎？</li>
<li>Axon 在財報發佈後大幅上漲，但仍比高點下跌超過 50%</li>
<li>可能重新定義蘋果夏季反彈的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Option Care Health 嗎？</h2>
<p>在考慮 Option Care Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Option Care Health 並不在名單上。</p>
<p>雖然 Option Care Health 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得投資。</p>
<p>在這裏查看這五隻股票</p>

拜爾斯普保健

醫療業 ETF - SPDR

標普全球醫療股指數 ETF - iShares

標普醫療保健服務 ETF - SPDR

醫療業 ETF - Vanguard

美國醫療保健供應商 ETF - iShares

<p>Zacks Research 將 Option Care Health (NASDAQ:OPCH) 的評級從 “持有” 下調至 “強烈賣出”。其他分析師的看法各不相同，Jefferies 維持 “買入” 評級，目標價為 37 美元，而 TD Cowen 將目標價下調至 23 美元。該股開盤價為 19.59 美元，下跌 1.2%，市值為 30.8 億美元。最近的內部購買包括首席執行官 John Rademacher 收購了 12,500 股。分析師預計 Option Care Health 本年度每股收益為 1.64 美元，普遍評級為 “適度買入”，平均目標價為 31.25 美元</p>

<p>Option Care Health (NASDAQ:OPCH - Get Free Report) was downgraded by stock analysts at Zacks Research from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a report released on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>Option Care Health（納斯達克股票代碼：OPCH - 獲取免費報告）在週一發佈的報告中被 Zacks Research 的股票分析師從 “持有” 評級下調至 “強烈賣出” 評級，Zacks.com 報道。</p>
</div><p>Get <strong>Option Care Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Option Care Health</strong> 的提醒：</p>
</div><ul>
<li>Option Care Health Stock is Making a Healthy Pullback</li>
</ul>
<div class="lb-trans"><ul>
<li>Option Care Health 股票正在進行健康的回調</li>
</ul>
</div><p>Several other equities research analysts have also commented on the company. Jefferies Financial Group restated a &#34;buy&#34; rating and set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. TD Cowen cut their target price on Option Care Health from $37.00 to $23.00 and set a &#34;hold&#34; rating on the stock in a research report on Friday, May 1st. Morgan Stanley set a $28.00 target price on Option Care Health in a research report on Wednesday, May 6th. Citizens Jmp restated a &#34;market outperform&#34; rating and set a $38.00 target price (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Barrington Research dropped their price target on Option Care Health from $42.00 to $32.00 and set an &#34;outperform&#34; rating on the stock in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $31.25.</p>
<div class="lb-trans"><p>其他幾位股票研究分析師也對該公司發表了評論。Jefferies Financial Group 在 1 月 13 日的研究報告中重申了 “買入” 評級，並將 Option Care Health 的目標價設定為 37.00 美元。TD Cowen 在 5 月 1 日的研究報告中將 Option Care Health 的目標價從 37.00 美元下調至 23.00 美元，並對該股票設定了 “持有” 評級。摩根士丹利在 5 月 6 日的研究報告中將 Option Care Health 的目標價設定為 28.00 美元。Citizens Jmp 在 1 月 13 日的研究報告中重申了 “市場跑贏大盤” 評級，並將 Option Care Health 的目標價設定為 38.00 美元（上調自 36.00 美元）。最後，Barrington Research 在 5 月 1 日的研究報告中將 Option Care Health 的目標價從 42.00 美元下調至 32.00 美元，並對該股票設定了 “跑贏大盤” 評級。一位股票研究分析師給予該股票 “強烈買入” 評級，八位給予 “買入” 評級，三位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，平均目標價為 31.25 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Option Care Health</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 Option Care Health 的最新股票報告</strong></p>
</div><h2>Option Care Health Stock Down 1.2%</h2>
<div class="lb-trans"><h2>Option Care Health 股票下跌 1.2%</h2>
</div><p>Shares of Option Care Health stock opened at $19.59 on Monday. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The stock's 50-day moving average is $27.52 and its 200 day moving average is $30.43. The firm has a market cap of $3.08 billion, a price-to-earnings ratio of 15.19, a PEG ratio of 1.10 and a beta of 0.68.</p>
<div class="lb-trans"><p>週一，Option Care Health 股票開盤價為 19.59 美元。Option Care Health 的年低為 18.01 美元，年高為 36.80 美元。該公司的債務與股本比率為 0.85，流動比率為 1.64，速動比率為 1.07。該股票的 50 日移動平均線為 27.52 美元，200 日移動平均線為 30.43 美元。該公司的市值為 30.8 億美元，市盈率為 15.19，PEG 比率為 1.10，貝塔值為 0.68。</p>
</div><p>Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter in the prior year, the company earned $0.40 EPS. The firm's revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts anticipate that Option Care Health will post 1.64 EPS for the current year.</p>
<div class="lb-trans"><p>Option Care Health（納斯達克股票代碼：OPCH - 獲取免費報告）最後一次公佈財報是在 4 月 30 日，報告顯示該公司本季度每股收益為 0.40 美元，超出市場共識預期的 0.37 美元，超出幅度為 0.03 美元。Option Care Health 的股本回報率為 18.17%，淨利潤率為 3.64%。該公司本季度的收入為 13.5 億美元，而分析師預期為 13.9 億美元。在去年同期，該公司每股收益為 0.40 美元。與去年同期相比，該公司的季度收入增長了 1.3%。Option Care Health 已將其 2026 財年的指引設定為 1.820-1.920 每股收益。股票研究分析師預計 Option Care Health 在當前年度將發佈 1.64 每股收益。</p>
</div><h2>Insider Transactions at Option Care Health</h2>
<div class="lb-trans"><h2>Option Care Health 的內部交易</h2>
</div><p>In related news, CEO John Charles Rademacher acquired 12,500 shares of the stock in a transaction dated Monday, May 4th. The stock was purchased at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy P. Sullivan acquired 24,154 shares of the stock in a transaction dated Thursday, May 7th. The stock was bought at an average cost of $20.69 per share, with a total value of $499,746.26. Following the completion of the purchase, the director owned 73,383 shares of the company's stock, valued at approximately $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 73,264 shares of company stock valued at $1,548,316 over the last ninety days. 1.70% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 John Charles Rademacher 在 5 月 4 日的交易中購買了 12,500 股該股票。該股票的平均購買成本為每股 21.18 美元，總價值為 264,750.00 美元。完成購買後，首席執行官直接持有該公司 695,152 股股票，價值為 14,723,319.36 美元。這筆交易代表其持股比例增加了 1.83%。該購買在向證券交易委員會的法律文件中披露，可以通過此鏈接訪問。此外，董事 Timothy P. Sullivan 在 5 月 7 日的交易中購買了 24,154 股該股票。該股票的平均購買成本為每股 20.69 美元，總價值為 499,746.26 美元。完成購買後，該董事持有 73,383 股公司的股票，價值約為 1,518,294.27 美元。這筆交易使其持股比例增加了 49.06%。有關此次購買的更多細節可在官方 SEC 披露中找到。在過去的九十天裏，內部人士共購買了 73,264 股公司股票，價值為 1,548,316 美元。目前，1.70% 的股票由內部人士持有。</p>
</div><h2>Institutional Trading of Option Care Health</h2>
<div class="lb-trans"><h2>Option Care Health 的機構交易</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. V Square Quantitative Management LLC purchased a new stake in shares of Option Care Health in the fourth quarter worth approximately $25,000. Cornerstone Planning Group LLC raised its stake in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock worth $30,000 after purchasing an additional 1,067 shares during the last quarter. McIlrath &amp; Eck LLC purchased a new stake in shares of Option Care Health in the second quarter worth approximately $37,000. Advisory Services Network LLC purchased a new stake in shares of Option Care Health in the third quarter worth approximately $35,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health in the third quarter worth approximately $38,000. 98.05% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近修改了對該股票的持有情況。V Square Quantitative Management LLC 在第四季度購買了 Option Care Health 的新股份，價值約為 25,000 美元。Cornerstone Planning Group LLC 在第三季度將其在 Option Care Health 的股份增加了 7,621.4%。Cornerstone Planning Group LLC 現在擁有該公司 1,081 股股票，價值 30,000 美元，此前在上個季度購買了 1,067 股。McIlrath &amp; Eck LLC 在第二季度購買了 Option Care Health 的新股份，價值約為 37,000 美元。Advisory Services Network LLC 在第三季度購買了 Option Care Health 的新股份，價值約為 35,000 美元。最後，Caitong International Asset Management Co. Ltd 在第三季度購買了 Option Care Health 的新股份，價值約為 38,000 美元。98.05% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Option Care Health Company Profile</h2>
<div class="lb-trans"><h2>Option Care Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.</p>
<div class="lb-trans"><p>Option Care Health（納斯達克：OPCH）是美國領先的家庭和替代場所輸液服務提供商。該公司專注於注射療法的管理，包括抗生素、營養、補液、免疫球蛋白、疼痛管理和特殊藥物。通過其全國性的輸液藥房和護理專業人員網絡，Option Care Health 為管理複雜或慢性病的患者提供定製的護理計劃和上門護理服務。</p>
</div><p>Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.</p>
<div class="lb-trans"><p>Option Care Health 的當前結構可追溯到 2021 年初與 BioScrip 合併的完成，結合了該行業中兩家經驗最豐富的家庭輸液業務。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Option Care Health</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Option Care Health</li>
<li>海軍催化劑點燃了 Odysight 的增長引擎</li>
<li>AST SpaceMobile 因銀河 Q1 業績不佳而暴跌：垂直整合能拯救這家 SpaceX 競爭對手嗎？</li>
<li>Axon 在財報發佈後大幅上漲，但仍比高點下跌超過 50%</li>
<li>可能重新定義蘋果夏季反彈的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=OPCH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Option Care Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Option Care Health 嗎？</h2>
</div><p>Before you consider Option Care Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Option Care Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Option Care Health 並不在名單上。</p>
</div><p>While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Option Care Health 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得投資。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Zacks Research

Market Beat

Jefferies Financial

摩根士丹利

Citizens Financial

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

拜爾斯普保健（NASDAQ 代碼：OPCH）的股票評級被 Zacks Research 下調